Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Buffers Stories

2014-04-01 08:28:22

MONMOUTH JUNCTION, N.J., April 1, 2014 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative technology-based products announced several key management changes, including the new appointment of Mr. Stephen J. Kovary to the position of Vice President of Operations. Mr. Kovary brings three decades of pharmaceutical experience in the areas of manufacturing, process improvement, facilities, engineering, plant and systems management. Prior to...

2014-03-11 23:32:47

Reliable Biopharmaceutical Corporation announces the launch of cGMP HEPES buffer to serve the biopharmaceutical industry. St. Louis, Missouri (PRWEB) March 11, 2014 cGMP HEPES Buffer is used in many critical processes by the biopharmaceutical industry. As regulations surrounding supply chain and excipient quality become more stringent, there is a need for high quality GMP commercial ingredient manufacturing. Reliable’s cGMP HEPES Buffer is manufactured following stringent cGMP...

2013-06-20 08:27:00

MONMOUTH JUNCTION, N.J., June 20, 2013 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that it has named Janet Penner as President of its new generic pharmaceuticals business. Tris' generic pharmaceuticals business, with its own distinct sales, marketing and distribution, will be responsible for commercializing Tris' Abbreviated New Drug Applications (ANDAs) while leveraging Tris' considerable...

2013-03-11 08:27:58

MONMOUTH JUNCTION, N.J., March 11, 2013 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, announced today receipt of a first milestone payment under its U.S. prescription cough/cold collaboration with Vernalis plc (Vernalis). This milestone recognizes the achievement by Tris of proof-of-concept (POC) for the first collaboration compound, CCP-01. Under the collaboration, POC required the successful...

2012-07-11 02:25:23

MONMOUTH JUNCTION, N.J., July 11, 2012 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company with fully integrated commercial manufacturing and drug development operations, announced today that in order to meet demand for its products (approved and near term) the company has fortified its supply chain, increased manufacturing capacity and strengthened its management team. During the past two months, Tris has been fortunate to receive five new ANDA approvals from the FDA, beginning...

2011-06-29 06:30:00

MONMOUTH JUNCTION, N.J., June 29, 2011 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, has appointed Ms. Cheryl Patnick to the position of Vice President of Human Resources. Ms. Patnick had been working with Tris as a consultant for about a year, and will now lead and manage Tris' human resource activities as an executive of the company. "Tris is at a point in its evolution where it needs leaders who are willing to take...

2010-10-07 07:00:00

MONMOUTH JUNCTION, N.J., Oct. 7 /PRNewswire/ -- Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced the US Food and Drug Administration (FDA) has approved first-ever generic of TUSSIONEX®, an Extended-Release Suspension containing hydrocodone polistirex and chlorpheniramine polistirex. Tussionex was approved in the 1980's based on 1970's technology involving organic solvent based coatings. Based on its highly...

2008-06-18 12:00:29

The Pennsylvania Campaign for Clean Water today publicly launched its "Buffers 100" initiative, urging the Pennsylvania Department of Environmental Protection (DEP) to propose new regulations that would require minimum 100 foot buffers on new development on all rivers and streams in the state. The proposal has been endorsed by 110 organizations, businesses and municipal organizations from across the state, along with 25 legislators from both parties and both chambers of the General Assembly....